Show Summary Details
Page of

Hepatitis C virus 

Hepatitis C virus
Hepatitis C virus

Paul Klenerman

, Katie J.M. Jeffery

, Ellie J. Barnes

, and Jane Collier

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 02 March 2021

Hepatitis C virus is a major cause of liver disease worldwide. It is estimated that globally 170 million people are affected. Infection is parenteral. In many countries most recent acquisition is in people who inject drugs, but transmission worldwide also occurs in in healthcare settings due to the reuse or inadequate sterilization of medical equipment and the transfusion of unscreened blood and blood products. Sexual transmission also occurs, particularly in men who have sex with men. The virus has a tendency to become persistent in most of those infected. However, a substantial minority (around 25%) do clear the virus as a result of effective innate and adaptive immune responses at the times of acute infection. In those with persistent infection, the clinical course is quite variable. Treatment with directly acting antiviral drugs is well tolerated and leads to very high cure rates in chronic disease.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.